Revolutionizing Bioanalysis: Harnessing AI for Enhanced Precision, Insights, and Efficiency
Does AI have a place in bioanalysis? We say YES!
In this session, tenured biomarker expert, Corinne Ramos, Phd, R&D Director at Aliri Bioanalysis, and Stephanie Papas-Farmer, PhD, President and Founder of BioData Solutions, share an overview of the state of AI in the drug development landscape, and real, data-backed bioanalytical applications for this powerful tool. Join us to explore how the power of AI in conjunction with genomic, proteomic, and metabolomic analyses can help predict the effectiveness of immunotherapies at an early stage in the drug development process, well before traditional methods would allow.
Watch the full-length recording below and reach out to learn how Aliri can enhance your drug development program and help you predict the effectiveness of immunotherapies earlier.
